Northern Trust’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-18,200
| Closed | -$71.3K | – | 4629 |
|
|
2023
Q3 | $71.3K | Buy |
+18,200
| New | +$124K | ﹤0.01% | 4084 |
|
|
2023
Q2 | – | Sell |
-4,717
| Closed | -$17K | – | 4615 |
|
|
2023
Q1 | $17K | Sell |
4,717
-32
| -0.7% | -$494 | ﹤0.01% | 4474 |
|
|
2022
Q4 | $153K | Sell |
4,749
-15
| -0.3% | -$594 | ﹤0.01% | 3966 |
|
|
2022
Q3 | $199K | Buy |
4,764
+1,157
| +32% | +$52.9K | ﹤0.01% | 3878 |
|
|
2022
Q2 | $152K | Sell |
3,607
-10,742
| -75% | -$498K | ﹤0.01% | 4021 |
|
|
2022
Q1 | $973K | Sell |
14,349
-673
| -4% | -$56K | ﹤0.01% | 3428 |
|
|
2021
Q4 | $1.82M | Buy |
15,022
+115
| +0.8% | +$19.4K | ﹤0.01% | 3261 |
|
|
2021
Q3 | $2.1M | Sell |
14,907
-1,226
| -8% | -$243K | ﹤0.01% | 3264 |
|
|
2021
Q2 | $4.43M | Buy |
16,133
+3,389
| +27% | +$855K | ﹤0.01% | 2910 |
|
|
2021
Q1 | $2.73M | Buy |
12,744
+1,335
| +12% | +$369K | ﹤0.01% | 3085 |
|
|
2020
Q4 | $2.76M | Buy |
11,409
+241
| +2% | +$29.8K | ﹤0.01% | 3020 |
|
|
2020
Q3 | $1.18M | Buy |
11,168
+2,486
| +29% | +$226K | ﹤0.01% | 3318 |
|
|
2020
Q2 | $851K | Buy |
8,682
+1,207
| +16% | +$106K | ﹤0.01% | 3407 |
|
|
2020
Q1 | $561K | Buy |
7,475
+493
| +7% | +$46.9K | ﹤0.01% | 3419 |
|
|
2019
Q4 | $567K | Buy |
6,982
+32
| +0.5% | +$3.58K | ﹤0.01% | 3529 |
|
|
2019
Q3 | $847K | Sell |
6,950
-10
| -0.1% | -$1.38K | ﹤0.01% | 3435 |
|
|
2019
Q2 | $1.25M | Buy |
6,960
+110
| +2% | +$17.8K | ﹤0.01% | 3287 |
|
|
2019
Q1 | $1.1M | Buy |
6,850
+442
| +7% | +$87.5K | ﹤0.01% | 3330 |
|
|
2018
Q4 | $1.67M | Buy |
6,408
+3,491
| +120% | +$703K | ﹤0.01% | 3148 |
|
|
2018
Q3 | $711K | Buy |
2,917
+1,955
| +203% | +$512K | ﹤0.01% | 3558 |
|
|
2018
Q2 | $227K | Buy |
+962
| New | +$280K | ﹤0.01% | 3817 |
|
Other funds holding EVLO
Northern Trust's EVLO Position: Q4 2023 in Review
Northern Trust sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q4 2023, closing a stake of 18,200 shares — an estimated $71.3K sold.
Northern Trust first reported a position in EVLO in Q2 2018 and held it in 21 quarters. The position peaked at $4.43M in Q2 2021. 2 funds tracked by Wall St. Rank hold EVLO as of Q4 2023.
- Northern Trust reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Northern Trust sold 18,200 Evelo Biosciences, Inc. Common Stock shares in Q4 2023, an estimated $71.3K.
- Northern Trust first reported a position in Evelo Biosciences, Inc. Common Stock in Q2 2018 and held it in 21 quarters.
- Northern Trust's Evelo Biosciences, Inc. Common Stock position peaked at $4.43M in Q2 2021.
- 2 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q4 2023.
Based on Northern Trust's 13F filing for Q4 2023, filed 13 Feb 2024.